EXAMINE THIS REPORT ON SUBUTEX URINARY RETENTION

The concomitant usage of buprenorphine and CYP3A4 inducers can decrease the plasma concentration of buprenorphine [see CLINICAL PHARMACOLOGY], likely leading to decreased efficacy or onset of a withdrawal syndrome in people who have produced Actual physical dependence to buprenorphine.In subjects with HCV infection but no indicator of hepatic impai